Latest Research
Autoantibody development is associated with clinical severity of COVID-19: A cohort study. March 2025
Management strategies in rheumatoid arthritis. Nat. Rev. Rheumatology. December 2024

Research Group of Helga Lechner-Radner

Research Group of Peter Mandl
We perform and interpret imaging studies encompassing all manifestations of rheumatic and musculoskeletal diseases and develop new diagnostic and therapeutic methods targeting fibroblasts.

Research Group of Clemens Scheineker
Autoimmunity and ImmunodeficiencyWe study, treat and manage patients with immune mediated inflammatory diseases as well as patients with primary or secondary immunodeficiencies.

Research Group of Daniela Sieghart
Biomarkers in rheumatic disordersWe study autoantibodies as potential biomarkers for diagnosis, management and prognosis of rheumatic conditions.

Research Group of Paul Studenic
We try to understand the validity of outcomes used in measuring disease activity, progression, quality of life and the interaction of patients with the health care system.